![Antonin Rollet de Fougerolles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antonin Rollet de Fougerolles
Direktor/Vorstandsmitglied bei
DEEPMATTER GROUP PLC
Profil
Antonin Rollet de Fougerolles is currently Chairman at eTheRNA immunotherapies NV since 2024.
Other current roles include Director at Chimeron Bio Corp., Director at Walking Fish Therapeutics, Inc., Non-Executive Director at ChemAI Ltd. since 2024, and Director at Valerio Therapeutics SA. Former positions include Chief Executive Officer & Director at Evox Therapeutics Ltd. from 2018 to 2024, Chief Scientific Officer at Tolerx, Inc. from 2010 to 2011, VP-Research, Immunology, Metabolic & Viral Disease at Alnylam Pharmaceuticals, Inc. from 2009 to 2010, Chief Scientific Officer at Ablynx NV from 2013 to 2018, and Chief Scientific Officer at ModernaTX, Inc. Education includes a doctorate from Harvard University.
Aktive Positionen von Antonin Rollet de Fougerolles
| Unternehmen | Position | Beginn |
|---|---|---|
| DEEPMATTER GROUP PLC | Direktor/Vorstandsmitglied | 27.11.2024 |
| VALERIO THERAPEUTICS | Direktor/Vorstandsmitglied | - |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Direktor/Vorstandsmitglied | - |
Chimeron Bio Corp.
 Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Direktor/Vorstandsmitglied | - |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics | Vorsitzender | 10.07.2024 |
Ehemalige bekannte Positionen von Antonin Rollet de Fougerolles
| Unternehmen | Position | Ende |
|---|---|---|
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Vorstandsvorsitzender | 29.04.2024 |
| ABLYNX | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2018 |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 19.12.2011 |
| ALNYLAM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Antonin Rollet de Fougerolles
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions | Technology Services |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Health Technology |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
